The Effect of Thiamine vs. Placebo on VO2 in Critical Illness (TVO2_RCT)
Sponsor: Beth Israel Deaconess Medical Center
This PHASE2 trial investigates Critically Ill and Respiratory Failure and is currently completed. Beth Israel Deaconess Medical Center leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE2
▶ Show 5 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Mar 2017 — Oct 2017 [monthly]
Completed PHASE2
Status: Unknown Status → Completed
-
Jan 2017 — Mar 2017 [monthly]
Unknown Status PHASE2
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beth Israel Deaconess Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .